Stroke Risk Assessment and Markers of Blood Clotting in Patients With Newly Diagnosed Non-valvular Atrial Fibrillation (NVAF), Who Have Not Received Oral Anticoagulation Therapy (OAC-therapy) Prior to Inclusion | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Stroke Risk Assessment and Markers of Blood Clotting in Patients With Newly Diagnosed Non-valvular Atrial Fibrillation (NVAF), Who Have Not Received Oral Anticoagulation Therapy (OAC-therapy) Prior to Inclusion	Arrhythmias, Cardiac, Embolism and Thrombosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, heart disorder, nervous system disorder, stroke disorder, thrombotic disease, vascular disorder	Recruiting	Not stated	2025-04-29		NCT06949319

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Direktør Kurt Bønnelycke og Hustru fru Grethe Bønnelyckes Fond	1
Esbjerg Hospital - University Hospital of Southern Denmark	33
Grosserer L.F. Foghts Foundation	2
Karola Jørgensens Foundation and Foundation for Cardiology in Southwest Denmark.	2
Nedim Tojaga	1
Region of Southern Denmark	22
Research Electronic Data Capture (REDCap)	1
The Faculty of Health Sciences SDU	1

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Esbjerg Hospital - University Hospital of Southern Denmark, involving collaboration between the Unit for Thrombosis Research, Department of Clinical Diagnostics and the Department of Cardiology.	Esbjerg	Denmark	1